In the first half of FY2025, we emerged from the downturn following the COVID-19-driven demand and entered a phase of gradual demand recovery. Although the business environment faced headwinds, including the stronger JPY and U.S. tariff policies, our Dental, Surgical, Industrial, and DCI segments remained generally firm. As a result, consolidated net sales totaled JPY 39.1 billion and EBITDA came to JPY 10.3 billion. Due to recording foreign exchange losses and income taxes for prior periods, ordinary profit was JPY 6.9 billion and profit attributable to owners of parents amounted to JPY 3.5 billion.

In March this year, the entire NAKANISHI Group exhibited at “IDS 2025,” the world’s largest dental trade show held in Cologne, Germany, and conducted vigorous marketing activities. The new dental handpieces and preventive dentistry products we unveiled to dentists and distribution partners from around the world were very well received, and we secured numerous business negotiations during the exhibition. We expect these initiatives to contribute to the expansion of our business performance going forward.

In the upcoming year 2030, NAKANISHI will celebrate its 100th anniversary. In anticipation of this important milestone, and to clarify the path the NAKANISHI Group should pursue, we formulated and announced our new Mid Term Management Plan, “NV2030.” Leveraging the “grinding technology” we have honed since our founding, we will create “brilliant progress” in this world. By realizing our mission, we will shape a better future. All employees of the NAKANISHI Group spread across the globe will advance as one team toward the next 100 years.